Mariana M. Cardoso
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparison of a recombinant endonuclease III protein and its synthetic peptides in ELISA for the diagnosis of tegumentary leishmaniasis using human serum and urine samples: A preliminary study.
Journal: PLoS neglected tropical diseases
Published: February 02, 2026
Diagnostic evaluation of a novel recombinant multi-epitope protein for paucibacillary and multibacillary leprosy.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: November 07, 2025
Recombinant small myristoylated protein-3 and synthetic peptide as diagnostic and prognostic biomarkers for tegumentary leishmaniasis.
Journal: Parasitology international
Published: September 17, 2025
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis.
Journal: Parasitology
Published: November 28, 2024
Serodiagnosis of paucibacillary and multibacillary leprosy using a recombinant chimeric protein composed of specific B-cell epitopes derived from Mycobacterium leprae proteins.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: November 21, 2023
A recombinant chimeric antigen constructed with B-cell epitopes from Mycobacterium leprae hypothetical proteins is effective for the diagnosis of leprosy.
Journal: Diagnostic microbiology and infectious disease
Published: November 08, 2023
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from Patients.
Journal: Viruses
Published: August 16, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026